Placental gene expression of calcitonin gene-related peptide and nitric oxide synthases in preeclampsia: effects of magnesium sulfate

Magnesium Research

Volumn 22, Issue 1, 2009, Pages 44-49

  Ariza, Ana Carolina ^a,c   Bobadilla, Norma ^b,c   Díaz, Lorenza ^a   Avila, Euclides ^a   Larrea, Fernando ^a   Halhali, Ali ^a,b  

^a Department of Reproductive Biology ^*  (Mexico)

^b INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^c INSTITUTO DE INVESTIGACIONES BIOMÉDICAS   (Mexico)

Author keywords

Calcitonin gene related peptide; Magnesium sulfate; Nitric oxide synthases; Placenta; Preeclampsia

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; CALCITONIN RECEPTOR; CALCITONIN RECEPTOR LIKE RECEPTOR; CALCITONIN RECEPTOR-LIKE RECEPTOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; MAGNESIUM SULFATE; MEMBRANE PROTEIN; MESSENGER RNA; NOS2A PROTEIN, HUMAN; NOS3 PROTEIN, HUMAN; RECEPTOR ACTIVITY MODIFYING PROTEIN; SIGNAL PEPTIDE;

ARTICLE; DRUG EFFECT; EVALUATION; FEMALE; GENE EXPRESSION; GENETICS; HUMAN; METABOLISM; PLACENTA; PREECLAMPSIA; PREGNANCY;

CALCITONIN GENE-RELATED PEPTIDE; FEMALE; GENE EXPRESSION; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MAGNESIUM SULFATE; MEMBRANE PROTEINS; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; RECEPTORS, CALCITONIN; RNA, MESSENGER;

EID: 66149095419     PISSN: 09531424     EISSN: 19524021     Source Type: Journal    
DOI: 10.1684/mrh.2009.0154     Document Type: Article

References (31)

1. National High Blood Pressure Education Program Working Group. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000; 183: S1-S22.
2. Sibai BM. Magnesium sulfate is the ideal anticonvulsant in preeclampsia-eclampsia. Am J Obstet Gynecol 1990; 162: 1141-5.
3. Witlin AG, Sibai BM. Magnesium sulfate therapy in pre- eclampsia and eclampsia. Obstet Gynecol 1998; 92: 883-9.
4. Ariza AC, Bobadilla N, Fernandez C, Munoz-Fuentes RM, Larrea F, Halhali A. Effects of magnesium sulfate on lipid peroxidation and blood pressure regulators in preeclampsia. Clin Biochem 2005; 38: 128-33.
5. Touyz RM. Role of magnesium in the pathogenesis of hypertension. Mol Aspects Med 2003; 24: 107-36.
6. Redman CW, Sargent IL. Latest advances in understand- ing preeclampsia. Science 2005; 308: 1592-4.
7. Granger JP, Alexander BT, Bennett WA, Khalil RA. Pathophysiology of pregnancy-induced hypertension. Am J Hypertens 2001; 14: 178S-185S.
8. Di Paolo S, Volpe P, Grandaliano G, Stallone G, Schena A, Greco P, Resta L, Selvaggi L, Cincione R, Schena FP, Gesualdo L. Increased placental expression of tissue factor is associated with abnormal uterine and umbili- cal Doppler waveforms in severe preeclampsia with fet al. growth restriction. J Nephrol 2003; 16: 650-7.
9. Napolitano M, Miceli F, Calce A, Vacca A, Gulino A, Apa R, Lanzone A. Expression and relationship between endothelin-1 messenger ribonucleic acid (mRNA) and inducible/endothelial nitric oxide synthase mRNA iso- forms from normal and preeclamptic placentas. J Clin Endocrinol Metab 2000; 85: 2318-23.
10. Orange SJ, Painter D, Horvath J, Yu B, Trent R, Hen- nessy A. Placental endothelial nitric oxide synthase localization and expression in normal human preg- nancy and pre-eclampsia. Clin Exp Pharmacol Physiol 2003; 30: 376-81.
11. Tranquilli AL, Giannubilo SR, Tedeschi E, Bezzeccheri V, Suzuki H, Menegazzi M. Placental expression of nitric oxide synthase during HELLP syndrome: the cor- relation with maternal-fet al. Doppler velocimetry. Acta Obstet Gynecol Scand 2005; 84: 849-53.
12. Moncada S, Higgs A, Furchgott R. International Union of Pharmacology Nomenclature in Nitric Oxide Research. Pharmacol Rev 1997; 49: 137-42.
13. Valerio A, Cardile A, Cozzi V, et al. TNF-alpha down- regulates eNOS expression and mitochondrial biogen- esis in fat and muscle of obese rodents. J Clin Invest 2006; 116: 2791-8.
14. Forstermann U, Boissel JP, Kleinert H. Expressional control of the 'constitutive' isoforms of nitric oxide synthase (NOS I and NOS III). FASEB J 1998; 12: 773-90.
15. Bomberger JM, Parameswaran N, Hall CS, Aiyar N, Spielman WS. Novel function for receptor activity- modifying proteins (RAMPs) in post-endocytic recep- tor trafficking. J Biol Chem 2005; 280: 9297-307.
16. Flahaut M, Rossier BC, Firsov D. Respective roles of calcitonin receptor-like receptor (CRLR) and receptor activity-modifying proteins (RAMP) in cell surface expression of CRLR/RAMP heterodimeric receptors. J Biol Chem 2002; 277: 14731-7.
17. Choi JW, Im MW, Pai SH. Nitric oxide production increases during normal pregnancy and decreases in preeclampsia. Ann Clin Lab Sci 2002; 32: 257-63.
18. Dong YL, Chauhan M, Green KE, et al. Circulating cal- citonin gene-related peptide and its placental origins in normotensive and preeclamptic pregnancies. Am J Ob- stet Gynecol 2006; 195: 1657-67.
19. Dong YL, Vegiraju S, Chauhan M, et al. Involvement of calcitonin gene-related peptide in control of human fetoplacental vascular tone. Am J Physiol Heart Circ Physiol 2004; 286: H230-H239.
20. Cruikshank DP, Pitkin RM, Reynolds WA, Williams GA, Hargis GK. Effects of magnesium sulfate treatment on perinatal calcium metabolism. I. Maternal and fet al. responses. Am J Obstet Gynecol 1979; 134: 243-9.
21. Sambrook J, Fritsch E, Maniatis T. Molecular cloning: a laboratory manual. New York: Cold Spring Harbor Laboratory Press, 1989.
22. Knerr I, Dachert C, Beinder E, et al. Adrenomedullin, calcitonin gene-related peptide and their receptors: evidence for a decreased placental mRNA content in preeclampsia and HELLP syndrome. Eur J Obstet Gynecol Reprod Biol 2002; 101: 47-53.
23. Cueille C, Birot O, Bigard X, Hagner S, Garel JM. Post- transcriptional regulation of CRLR expression during hypoxia. Biochem Biophys Res Commun 2005; 326: 23-9.
24. Halhali A, Wimalawansa SJ, Berentsen V, Avila E, Thota CS, Larrea F. Calcitonin gene- and parathyroid hormone-related peptides in preeclampsia: effects of magnesium sulfate. Obstet Gynecol 2001; 97: 893-7.
25. Freeland K, Liu YZ, Latchman DS. Distinct signalling pathways mediate the cAMP response element (CRE) -dependent activation of the calcitonin gene- related peptide gene promoter by cAMP and nerve growth factor. Biochem J 2000; 345 (Pt 2) : 233-8.
26. Moll JR, Acharya A, Gal J, Mir AA, Vinson C. Magne- sium is required for specific DNA binding of the CREB B-ZIP domain. Nucleic Acids Res 2002; 30: 1240-6.
27. Chakravarty P, Suthar TP, Coppock HA, et al. CGRP and adrenomedullin binding correlates with transcript levels for calcitonin receptor-like receptor (CRLR) and receptor activity modifying proteins (RAMPs) in rat tis- sues. Br J Pharmacol 2000; 130: 189-95.
28. Kim YH, Kim CH, Cho MK, et al. Total peroxyl radical- trapping ability and anti-oxidant vitamins of the umbil- ical venous plasma and the placenta in pre-eclampsia. J Obstet Gynaecol Res 2006; 32: 32-41.
29. Kim YJ, Park HS, Lee HY, et al. Reduced L-arginine level and decreased placental eNOS activity in pre- eclampsia. Placenta 2006; 27: 438-44.
30. Holcberg G, Sapir O, Hallak M, et al. Selective vasodi- lator effect of magnesium sulfate in human placenta. Am J Reprod Immunol 2004; 51: 192-7.
31. Shogi T, Miyamoto A, Ishiguro S, Nishio A. Enhanced release of IL-lbeta and TNF-alpha following endotoxin challenge from rat alveolar macrophages cultured in low-Mg (2+) medium. Magnes Res 2003; 16: 111-9.